Financial Reports Latest Updates Industry Maps Economic Calendar

Xencor Inc (XNCR) Annual Reports

Q: Where can I read Xencor Inc (XNCR) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Xencor Inc is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1326732 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$51.2M	$43.6M	+17.5%
Operating income	$-37.1M	$-33.2M	-11.7%
Net income	$-21.7M	$-30.8M	+29.5%
EPS (diluted)	$-0.29	$-0.41	+29.3%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 51.2 mn Net income -21.7 mn

Show table：Income statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	—	—	—	—	—	—	—	109	3.50	12.5	0	30.1	—	—	29.0	11.6	112	19.5	21.8	3.52	32.4	13.1	35.4	41.9	34.0	67.5	19.7	154	85.5	30.2	27.3	21.6	19.0	45.5	59.2	44.7	12.8	17.0	10.7	70.0	32.7	43.6	21.0	28.2	4.52	51.2
Operating income	-3.71	-3.77	-5.05	-6.29	-1.35	-6.48	-8.99	-10.3	7.44	-6.73	48.6	-9.26	-10.0	-15.5	-7.67	-16.5	-13.9	-30.6	-28.3	0.65	-21.1	78.2	-19.6	-14.3	-30.6	-8.78	-37.6	-16.7	-13.7	-15.7	9.09	-41.3	91.7	26.5	-28.0	-38.4	-42.6	-59.4	-26.0	-18.3	-35.0	-57.9	-62.3	-62.3	4.05	-43.2	-33.2	-47.5	-53.6	-77.9	-37.1
Net income	-60.3	-3.75	-5.04	-6.28	-1.35	-6.44	-8.87	-10.0	7.76	-6.40	47.2	-8.08	-9.06	-14.6	-6.88	-15.6	-11.8	-29.5	-25.9	3.15	-18.2	80.0	-16.0	-10.2	-26.9	-8.07	-35.0	-12.6	-13.7	-2.49	52.3	-40.2	73.1	23.6	-34.0	-32.8	-12.0	-60.8	-21.9	-24.3	-19.1	-68.0	-66.0	-45.1	-53.5	-48.4	-30.8	-6.03	-6.65	-129	-21.7

Balance sheet

Quarterly · In mn (USD)

Total assets 725 mn Total liabilities 222 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	78.1	73.2	66.7	61.1	57.8	145	69.7	130	97.7	94.8	244	111	142	166	211	218	231	471	270	287	316	489	527	574	558	588	603	571	638	591	481	330	424	506	586	668	675	630	594	571	623	562	554	573	578	521	513	518	600	483	523
Total assets	87.3	82.5	76.4	70.9	67.8	179	173	211	207	194	334	322	429	418	416	398	390	612	591	586	577	697	685	686	670	667	645	646	703	693	696	697	838	858	851	835	846	803	778	778	953	884	826	984	952	905	879	869	876	737	725
Current liabilities	7.48	6.83	5.95	9.93	6.20	6.88	8.41	56.6	43.4	34.3	116	111	106	107	107	100	101	73.4	71.2	52.0	53.9	73.3	63.7	64.3	66.6	65.9	66.5	70.5	121	99.9	46.0	44.3	70.7	60.9	75.0	90.0	63.8	65.1	44.6	53.0	84.7	79.4	80.1	92.0	87.4	88.4	96.1	86.5	95.9	73.5	81.9
Total liabilities	13.8	12.4	10.8	11.2	8.53	9.34	10.5	58.2	44.5	35.1	126	120	115	115	115	108	108	74.6	72.3	53.3	55.0	87.4	76.7	76.0	77.0	74.0	74.1	77.9	131	109	48.7	78.4	105	94.9	109	113	119	120	99.3	109	284	272	264	263	278	265	259	244	240	221	222
Equity	73.5	70.1	65.5	59.7	59.3	169	162	153	162	159	209	202	314	304	301	291	282	538	519	532	522	610	608	610	593	593	571	568	572	584	647	619	734	763	742	723	728	684	679	669	669	613	564	724	678	640	620	625	636	516	503

Cash flow

Quarterly · In mn (USD)

Operating -55.7 mn Investing 85.1 mn Financing 1.03 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-4.15	-4.99	-5.77	-4.72	-5.86	-2.09	-6.92	39.5	-3.84	-14.3	-9.37	134	-15.8	-10.6	-13.0	-3.51	-6.67	-24.2	-28.4	-10.3	-16.8	-18.7	109	-6.48	-19.6	9.46	-27.7	-3.87	17.1	-30.0	-9.65	-39.0	61.8	5.82	44.3	-1.17	-24.4	-30.6	-38.2	-27.3	181	-55.3	-65.3	-26.0	-55.6	-16.2	-36.4	-30.8	-51.7	-67.6	-55.7
Investing	-0.01	-0.45	-0.67	-0.57	-0.59	-49.1	-101	6.93	-41.7	9.66	8.62	-128	-104	8.55	9.53	4.93	8.94	12.7	-190	5.86	6.87	13.7	-102	22.1	15.7	12.6	59.4	-50.6	78.8	38.0	-53.3	-38.9	7.86	-71.8	-75.6	3.13	24.6	48.1	-1.40	45.3	-203	32.3	66.0	-163	57.3	13.7	40.5	14.7	71.2	26.7	85.1
Financing	72.5	0	0.13	0	0.18	116	0.33	0.11	0.39	0.2	0.47	0.5	120	1.03	1.10	0.99	0.62	247	2.31	4.15	1.17	0.67	3.97	3.05	2.97	1.47	4.00	2.99	9.59	5.34	1.84	3.23	32.6	0.73	2.51	1.29	1.17	0.92	1.92	0.36	23.0	0.19	-0.94	188	10.2	1.25	0.66	0	6.32	0.95	1.03
Cash at period end	78.0	72.5	66.2	60.9	54.6	119	11.2	57.7	12.6	8.15	7.88	14.8	14.5	13.6	11.2	13.6	16.5	252	35.3	35.0	26.3	21.9	32.6	51.2	50.3	73.8	110	58.1	164	177	116	41.2	143	78.3	49.4	52.6	53.9	72.4	34.7	52.7	53.8	31.0	30.8	29.0	40.9	39.7	44.4	28.3	54.1	14.2	44.7

Profitability

Quarterly · %

Operating margin -72.4% Net margin -42.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	—	—	—	—	—	—	—	—	-9.2%	-443.4%	-61.4%	—	-46.0%	—	—	2.2%	-182.3%	69.9%	-100.5%	-65.6%	-869.5%	-27.1%	-287.3%	-47.3%	-32.7%	-46.1%	13.5%	-209.8%	59.5%	31.0%	-92.8%	-140.5%	-197.1%	-313.1%	-57.1%	-30.9%	-78.3%	-451.8%	-367.4%	-581.5%	5.8%	-131.9%	-76.1%	-226.3%	-189.9%	-1724.1%	-72.4%
Net margin	—	—	—	—	—	—	—	—	—	—	—	—	-8.3%	-418.1%	-55.1%	—	-39.3%	—	—	10.8%	-157.4%	71.5%	-82.3%	-47.0%	-765.4%	-24.9%	-267.5%	-35.5%	-32.7%	-7.3%	77.5%	-204.2%	47.4%	27.6%	-112.6%	-120.0%	-55.7%	-320.4%	-48.2%	-41.0%	-42.7%	-531.3%	-388.9%	-421.5%	-76.4%	-147.9%	-70.7%	-28.7%	-23.6%	-2854.7%	-42.4%

Returns & leverage

Quarterly · %

ROE -29.1% ROA -20.4% Debt ratio 30.6%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-126.2%	-24.7%	-16.0%	-20.2%	-25.1%	-15.9%	-10.7%	20.8%	22.7%	9.9%	6.7%	-15.2%	-18.7%	-16.4%	-15.2%	-20.2%	-15.6%	-17.5%	6.8%	8.7%	6.2%	4.8%	-10.2%	-13.6%	-14.0%	-11.9%	-10.8%	3.9%	-0.7%	12.7%	16.1%	3.2%	4.5%	-7.5%	-19.3%	-17.9%	-17.1%	-18.1%	-20.6%	-28.5%	-28.5%	-34.5%	-34.0%	-30.0%	-20.6%	-14.0%	-29.8%	-29.1%
ROA	—	—	—	-106.3%	-21.2%	-14.6%	-18.4%	-18.9%	-12.8%	-9.4%	15.2%	15.2%	7.4%	5.0%	-10.3%	-12.8%	-11.9%	-12.4%	-16.4%	-13.0%	-14.6%	6.0%	7.7%	5.6%	4.3%	-9.0%	-12.1%	-12.4%	-10.1%	-9.4%	3.5%	-0.6%	10.7%	14.0%	2.9%	3.9%	-6.5%	-16.8%	-15.7%	-14.8%	-14.0%	-15.8%	-22.1%	-22.5%	-24.4%	-23.8%	-20.9%	-15.0%	-10.1%	-21.0%	-20.4%
Debt ratio	15.8%	15.1%	14.2%	15.7%	12.6%	5.2%	6.1%	27.5%	21.5%	18.1%	37.6%	37.2%	26.7%	27.4%	27.6%	27.1%	27.7%	12.2%	12.2%	9.1%	9.6%	12.5%	11.2%	11.1%	11.5%	11.1%	11.5%	12.1%	18.6%	15.8%	7.0%	11.2%	12.5%	11.1%	12.8%	13.5%	14.0%	14.9%	12.8%	14.1%	29.8%	30.8%	31.9%	26.7%	29.2%	29.3%	29.5%	28.0%	27.4%	30.0%	30.6%

EPS

Quarterly · US$

EPS US$-0.29

Show table：EPS

Item	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	-0.37	-0.12	-0.16	-0.20	-0.04	-0.19	-0.22	-0.25	0.19	-0.16	1.13	-0.20	-0.21	-0.31	-0.15	-0.33	-0.25	-0.62	-0.46	0.05	-0.32	1.38	-0.28	-0.18	-0.47	-0.14	-0.61	-0.22	-0.24	-0.04	0.87	-0.69	1.21	0.39	-0.57	-0.55	-0.21	-1.02	-0.37	-0.40	-0.31	-1.11	-1.07	-0.71	-0.71	-0.66	-0.41	-0.08	-0.09	-1.71	-0.29

Revenue & profit

Year-to-date · In mn (USD)

Revenue 55.7 mn Net income -151 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 725 mn Total liabilities 222 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -123 mn Investing 112 mn Financing 1.98 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin -206.2% Net margin -270.3%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -29.1% ROA -20.4% Debt ratio 30.6%

EPS

Year-to-date · US$

EPS US$-2.00

Revenue & profit

Annual · In mn (USD)

Revenue 126 mn Net income -91.9 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	—	—	46.1	—	157	123	275	165	168	110	126
Operating income	-16.5	-18.3	22.5	-53.6	-79.4	13.8	-76.8	43.8	-82.5	-139	-178	-177
Net income	-16.4	-17.6	23.6	-48.9	-70.4	26.9	-69.3	82.6	-55.2	-126	-233	-91.9

Balance sheet

Annual · In mn (USD)

Total assets 876 mn Total liabilities 240 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	57.8	97.7	142	231	316	558	638	424	675	623	578	600
Total assets	67.8	207	429	390	577	670	703	838	846	953	952	876
Current liabilities	6.20	43.4	106	101	53.9	66.6	121	70.7	63.8	84.7	87.4	95.9
Total liabilities	8.53	44.5	115	108	55.0	77.0	131	105	119	284	278	240
Equity	59.3	162	314	282	522	593	572	734	728	669	678	636

Cash flow

Annual · In mn (USD)

Operating -135 mn Investing 140 mn Financing 8.23 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-21.4	26.7	94.6	-33.7	-79.8	64.4	-5.00	-16.9	24.5	85.1	-202	-135
Investing	-2.28	-185	-214	31.9	-165	-51.0	100	-46.3	-120	-111	-7.87	140
Financing	0.31	116	121	3.73	254	10.7	18.0	43.0	5.70	26.2	197	8.23
Cash at period end	54.6	12.6	14.5	16.5	26.3	50.3	164	143	53.9	53.8	40.9	54.1

Profitability

Annual · %

Operating margin -141.3% Net margin -73.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	—	—	-116.1%	—	8.8%	-62.6%	15.9%	-50.1%	-82.4%	-161.5%	-141.3%
Net margin	—	—	—	-106.0%	—	17.1%	-56.5%	30.0%	-33.5%	-74.9%	-210.5%	-73.2%

Returns & leverage

Annual · %

ROE -14.0% ROA -10.1% Debt ratio 27.4%

Show table：Returns & leverage

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-27.7%	-15.9%	9.9%	-16.4%	-17.5%	4.8%	-11.9%	12.7%	-7.5%	-18.1%	-34.5%	-14.0%
ROA	-24.2%	-12.8%	7.4%	-11.9%	-14.6%	4.3%	-10.1%	10.7%	-6.5%	-14.0%	-24.4%	-10.1%
Debt ratio	12.6%	21.5%	26.7%	27.7%	9.6%	11.5%	18.6%	12.5%	14.0%	29.8%	29.2%	27.4%

EPS

Annual · US$

EPS US$-1.24

Show table：EPS

Item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	-0.52	-0.47	0.56	-1.04	-1.35	0.45	-1.21	1.35	-0.94	-2.10	-3.60	-1.24

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Xencor Inc (XNCR) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.